Botox Research Today is a free monthly online journal that collates and summarizes the latest research about Botox, including details on cosmetic botox, side-effects, alternatives, treatment.

Volume 5 (2008), Issue 7 (July)

1. Biosimilars: illustration of scientific issues in two examples.
   Am J Health Syst Pharm, 65(14): S9-15. [Abstract] [Full-text]
2. Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients.
   Dig Liver Dis, 40(8): 667-72. [Abstract] [Full-text]
3. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
   Neurology, 71(2): 122-8. [Abstract] [Full-text]
4. Effects of purification on the bioavailability of botulinum neurotoxin type A.
   Toxicology, 249(2): 123-9. [Abstract] [Full-text]
5. Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A.
   Appl Environ Microbiol, 74(14): 4309-13. [Abstract] [Full-text]
6. Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters.
   Appl Environ Microbiol, 74(14): 4390-7. [Abstract] [Full-text]
7. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat.
   J Urol, 180(2): 742-8. [Abstract] [Full-text]
8. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
   J Oral Maxillofac Surg, 66(8): 1644-51. [Abstract] [Full-text]
9. Botulinum toxin: future developments.
   BJU Int, 102: 20-2. [Abstract] [Full-text]
10. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity.
    BJU Int, 102: 17-9. [Abstract] [Full-text]
11. Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity.
    BJU Int, 102: 11-6. [Abstract] [Full-text]
12. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
    BJU Int, 102: 7-10. [Abstract] [Full-text]
13. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
    BJU Int, 102: 2-6. [Abstract] [Full-text]

© 2004-2012 Botox Research Today. All Rights Reserved.